Unknown

Dataset Information

0

Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection.


ABSTRACT: Chronic granulomatous disease (CGD) is an inherited immunodeficiency due to defective leukocyte NADPH responsible for recurrent infections and aberrant inflammation. Mutations in the CYBB gene are responsible for the X-linked CGD and account for approximately 70% of the cases. CGD is diagnosed during childhood in males. Female carriers may have biased X-inactivation and may present with clinical manifestations depending on the level of residual NADPH oxidase activity. We report the case of a previously asymptomatic female carrier who was diagnosed at age 67 with a skin infection with the rare fungus Paecilomyces lilacinus as the first manifestation of CGD. Dihydrorhodamine 123 (DHR) activity was below 10%. Next-generation sequencing (NGS) revealed mutations in DNMT3A, ASXL1, and STAG2 suggesting that clonal hematopoiesis could be responsible for a progressive loss of NADPH oxidase activity and the late onset of X-linked CGD in this patient. Long-term follow-up of asymptomatic carrier women seems to be essential after 50 years old.

SUBMITTER: Lemaigre C 

PROVIDER: S-EPMC8821496 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection.

Lemaigre Clément C   Suarez Felipe F   Martellosio Jean-Philippe JP   Barbarin Cindy C   Brunet Kévin K   Chomel Jean Claude JC   Hainaut Ewa E   Rammaert Blandine B   Roblot France F   Torregrosa-Diaz José Miguel JM  

Journal of clinical immunology 20211001 1


Chronic granulomatous disease (CGD) is an inherited immunodeficiency due to defective leukocyte NADPH responsible for recurrent infections and aberrant inflammation. Mutations in the CYBB gene are responsible for the X-linked CGD and account for approximately 70% of the cases. CGD is diagnosed during childhood in males. Female carriers may have biased X-inactivation and may present with clinical manifestations depending on the level of residual NADPH oxidase activity. We report the case of a pre  ...[more]

Similar Datasets

| S-EPMC2443355 | biostudies-literature
| S-EPMC3558921 | biostudies-literature
| S-EPMC5127417 | biostudies-literature
| S-EPMC4519919 | biostudies-literature
| S-EPMC7928956 | biostudies-literature
| S-EPMC2650454 | biostudies-literature
| S-EPMC8858869 | biostudies-literature
2003-12-31 | GSE935 | GEO
| S-EPMC10876222 | biostudies-literature
| S-EPMC8120492 | biostudies-literature